Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 4 | 2 | 0 | 0 | 0 |
| Cost of Goods | 5 | 1 | N/A | N/A | N/A |
| Gross Profit | -1 | 1 | N/A | N/A | N/A |
| Operating Expenses | 1,854 | 1,147 | 800 | 15,557 | 668 |
| Operating Income | -1,849 | -1,146 | -800 | -15,557 | -668 |
| Interest Expense | 6,233 | 1,480 | 528 | 290 | 0 |
| Other Income | 3,375 | 775 | -654 | -95 | -97 |
| Pre-tax Income | -4,708 | -1,851 | -1,981 | -15,941 | -765 |
| Net Income Continuous | -4,708 | -1,851 | -1,981 | -15,941 | -765 |
| Net Income | $-4,708 | $-1,851 | $-1,981 | $-15,941 | $-766 |
| EPS Basic Total Ops | 3.62 | -1.60 | -1.60 | -16.80 | -1.10 |
| EPS Basic Continuous Ops | 3.55 | -1.49 | -1.61 | -16.83 | -1.11 |
| EPS Diluted Total Ops | 3.62 | -1.60 | -1.60 | -16.80 | -1.10 |
| EPS Diluted Continuous Ops | 3.55 | -1.49 | -1.61 | -16.83 | -1.11 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.60 | -1.60 | -16.80 | N/A |
| EBITDA(a) | $4,149 | $-1,146 | $-800 | $-15,557 | $-668 |